XML 25 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2013
Income Tax Disclosure [Abstract]  
Income Taxes
4.  Income Taxes 
 
The Company has recorded a full valuation allowance against its net deferred tax assets as management believes that, after considering all the available objective evidence, both positive and negative, historical and prospective, with greater weight given to historical evidence, it is more likely than not that the deferred tax assets at September 30, 2013 will not be realized.
 
At September 30, 2013, the Company had available net operating loss carryforwards for federal and state income tax purposes of approximately $18,600,000 and $14,200,000, respectively, which may be used to offset future taxable income, subject to the limits discussed below.  The transaction for the AMS Inc. acquisition most closely resembles a Type C reorganization under IRC Section 368 (a1C).  In a Type C reorganization one corporation acquires nearly all properties of another corporation in exchange solely for all or a part of  its own or its  controlling parent’s voting stock followed by the acquired corporation’s distribution of all its  properties pursuant to the plan of reorganization.  This type of transaction qualifies as a non-taxable transaction under IRC Section 368 (a1C).  These Net Operating Losses (NOLs) are subject to review and possible adjustment by the Internal Revenue Service (“IRS”) and state tax authorities. The federal NOLs expire at various dates through 2032. For state purposes, Massachusetts has a five year net operating loss carryover rule for tax years beginning before January 1, 2010. At September 30, 2013, there are $3,700,000 in Massachusetts NOLs set to expire at various dates through 2015. For tax years beginning on or after January 1, 2010, Massachusetts has adopted a twenty year NOL carryover rule and has $10,200,000 in net operating loss carryforwards that are set to expire at various dates through 2032. The Company has available net operating loss carryforwards for New York State purposes in the amount of $300,000 that are set to expire at various dates through 2032.
 
In addition, $87,000 of Massachusetts investment tax and research and development credits are available to the Company as carryforwards, expiring in various dates through 2015. Of these credits $4,000 of investment tax and $22,000 of R&D are subject to IRC Section 382 as they are considered as part of the pre-change losses and are fully limited.  The remaining $61,000 do not expect to be utilized until the Massachusetts net operating loss carryforward is exhausted and is fully reserved for in the Company’s deferred tax valuation allowance.